GlassScriptPhysician profile
Benjamin S Jones
NPI 1134447980
$18,556.17
in general payments reported to CMS, 2019-2025
79 companies · $1,781 in 2025
The $1,781 reported for 2025 was more than what a typical Hematology & Oncology provider received nationally (typical 2025 total: $686).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,480 · 2020: $2,095 · 2021: $2,794 · 2022: $3,393 · 2023: $2,610 · 2024: $2,403 · 2025: $1,781.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,755 · Education: $38.38.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,755.14 |
| Education | $38.38 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $1,707.36 | 2019-2025 | |
| Merck Sharp & Dohme LLC | $1,247.50 | 2019-2025 | Keytruda, Lynparza, Welireg |
| Abbvie INC. | $1,037.45 | 2019-2025 | |
| E.R. Squibb & Sons, L.L.C. | $944.95 | 2019-2025 | Opdivo, Opdualag, Augtyro |
| Seagen INC. | $917.02 | 2019-2023 | Adcetris, Tukysa, Padcev |
| Amgen INC. | $892.90 | 2019-2023 | Kyprolis, Blincyto |
| Pfizer INC. | $810.40 | 2019-2025 | |
| Astrazeneca Pharmaceuticals LP | $805.50 | 2019-2025 | Enhertu, Calquence, Lynparza |
| Janssen Biotech, INC. | $790.40 | 2019-2025 | Tecvayli, Darzalex, Talvey |
| Genentech USA, INC. | $584.15 | 2019-2024 | Tecentriq, Venclexta, Lunsumio |
| Eisai INC. | $559.83 | 2019-2024 | |
| Celgene Corporation | $527.72 | 2019-2025 | Reblozyl, Pomalyst, Opdualag |
| Takeda Pharmaceuticals U.S.A., INC. | $519.85 | 2019-2025 | Ninlaro, Iclusig |
| Exelixis INC. | $421.62 | 2019-2024 | Cabometyx |
| Octapharma USA, INC. | $413.54 | 2020-2025 | Octagam Immune Globulin (Human) |
Show all 78 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Gilead Sciences, INC. | $403.59 | 2019-2025 | Trodelvy |
| Incyte Corporation | $362.24 | 2019-2025 | Jakafi, Monjuvi, Pemazyre |
| Pharmacyclics LLC, An Abbvie Company | $325.71 | 2019-2023 | Imbruvica, Epkinly |
| Genzyme Corporation | $308.25 | 2019-2024 | |
| Bayer Healthcare Pharmaceuticals INC. | $304.59 | 2019-2024 | |
| Astellas Pharma US INC | $257.83 | 2019-2025 | Xtandi, Xospata, Padcev |
| Lilly USA, LLC | $240.94 | 2019-2023 | Retevmo, Jaypirca, Verzenio |
| Glaxosmithkline, LLC. | $239.23 | 2019-2024 | Ojjaara, Zejula, Jemperli |
| Array Biopharma INC | $225.06 | 2019-2025 | Braftovi, Mektovi, Xalkori |
| Deciphera Pharmaceuticals INC. | $225.05 | 2020-2025 | Qinlock, Romvimza, Tgct |
| Alexion Pharmaceuticals, INC. | $178.40 | 2019-2023 | Ultomiris |
| Kite Pharma, INC. | $163.13 | 2021-2025 | Yescarta |
| Ipsen Biopharmaceuticals, INC | $154.82 | 2020-2023 | Somatuline Depot, Onivyde |
| Regeneron Healthcare Solutions, INC. | $153.91 | 2019-2024 | Libtayo |
| Daiichi Sankyo INC. | $152.24 | 2019-2024 | Enhertu |
| Janssen Pharmaceuticals, INC | $146.39 | 2019-2022 | |
| Sobi, INC | $131.25 | 2022-2025 | |
| Ethicon INC. | $125.00 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $119.14 | 2019-2025 | Gilotrif |
| Kyowa Kirin, INC. | $107.48 | 2019-2025 | |
| Pharmacosmos Therapeutics INC. | $101.21 | 2021-2022 | |
| Lexicon Pharmaceuticals, INC. | $99.73 | 2019 | |
| Jazz Pharmaceuticals INC. | $92.15 | 2020-2024 | |
| Blueprint Medicines Corporation | $88.62 | 2020-2022 | |
| Puma Biotechnology, INC. | $85.10 | 2019-2023 | Nerlynx |
| Karyopharm Therapeutics INC. | $80.43 | 2020-2022 | |
| Beone Medicines USA, INC. | $79.84 | 2025 | Brukinsa, Tevimbra |
| Sanofi-Aventis U.S. LLC | $79.02 | 2024 | |
| Stemline Therapeutics INC. | $73.50 | 2023-2025 | Orserdu |
| Aveo Pharmaceuticals, INC. | $71.73 | 2022-2024 | Fotivda |
| Myriad Genetic Laboratories, INC. | $65.27 | 2021-2024 | Myrisk, Precisetumor |
| Beigene USA, INC. | $64.39 | 2020-2023 | Brukinsa |
| Dova Pharmaceuticals | $63.54 | 2020-2021 | |
| Novocure INC. | $57.87 | 2021-2025 | Optune Lua (Novottf-200t) |
| Mirati Therapeutics, INC. | $56.39 | 2023-2024 | Krazati |
| Emd Serono, INC. | $55.72 | 2019-2022 | |
| Epizyme, INC. | $55.05 | 2021-2022 | |
| Tesaro, INC. | $54.70 | 2019 | |
| Morphosys, US INC. | $46.96 | 2022-2023 | Monjuvi |
| Rigel Pharmaceuticals, INC. | $45.84 | 2019-2023 | Tavalisse, Rezlidhia |
| Servier Pharmaceuticals LLC | $44.30 | 2024-2025 | |
| Taiho Oncology, INC. | $44.03 | 2020-2022 | |
| Adc Therapeutics America, INC. | $43.61 | 2021-2024 | |
| Acrotech Biopharma INC. | $42.11 | 2022-2023 | Beleodaq |
| Tempus Ai, INC | $35.42 | 2024-2025 | Xt Cdx |
| Tersera Therapeutics LLC | $35.30 | 2022 | |
| Pharmaessentia USA Corporation | $31.59 | 2023 | Besremi |
| Sumitomo Pharma America, INC. | $31.20 | 2023 | Orgovyx |
| Genmab U.S., INC. | $30.30 | 2023 | Epkinly |
| Iovance Biotherapeutics, INC. | $30.22 | 2024-2025 | Amtagvi |
| Myovant Sciences INC. | $30.11 | 2021 | |
| Helsinn Therapeutics (U.S.), INC. | $29.92 | 2019-2021 | |
| Amag Pharmaceuticals, INC. | $29.85 | 2019-2021 | |
| Boston Scientific Corporation | $27.67 | 2019-2025 | Wavewriter Alpha Prime 16 |
| Apellis Pharmaceuticals, INC. | $22.88 | 2023 | Empaveli |
| Shire North American Group INC | $18.42 | 2019 | |
| Clovis Oncology, INC. | $18.25 | 2019 | |
| Adaptive Biotechnologies Corporation | $18.11 | 2023 | Clonoseq |
| Caris Mpi, INC. | $17.29 | 2025 | Mi Cancer Seek |
| Foundation Medicine, INC. | $15.46 | 2020 | |
| Fennec Pharmaceuticals, INC. | $14.08 | 2025 | Fyarro |
| Tg Therapeutics, INC. | $12.42 | 2021 | |
| Immunomedics, INC. | $12.13 | 2020 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
Keytruda $520Kisqali $427Venclexta $315Enhertu $247Imbruvica $223Tecvayli $220Scemblix $207Epkinly $201Darzalex $200Lynparza $191Xtandi $178Tukysa $177Octagam Immune Globulin (Human) $172Adcetris $165Padcev $143Opdivo $139Creon $135Trodelvy $131Elrexfio $121Opdualag $104Mektovi $100Braftovi $100Calquence $100Qinlock $97.50Ninlaro $93.84Inlyta $93.08Talvey $92.14Talzenna $87.19Cabometyx $86.88Yescarta $86.48Lorbrena $83.04Ibrance $82.90Bosulif $82.55Monjuvi $81.18Tasigna $77.36Tecentriq $75.14Reblozyl $75.10Orserdu $73.50Brukinsa $72.72Orgovyx $71.05Rybrevant $70.41Lenvima $68.86Xalkori $67.54Xospata $63.82Elahere $62.50Jakafi $61.84Welireg $60.15Lunsumio $60.05Polivy $60.05Pemazyre $58.58Fotivda $56.70Krazati $56.39Pluvicto $52.18Mekinist $48.62Retevmo $48.58Somatuline Depot $48.41Onivyde $48.41Fabhalta $47.87Gilotrif $47.53Vonjo $44.87Xofigo $44.03Nubeqa $44.03Sarclisa $43.78Verzenio $42.79Jaypirca $42.79Stivarga $42.60Vitrakvi $42.60Carvykti $42.23Piqray $40.33Phesgo $38.36Pomalyst $38.02Promacta $38.01Libtayo $36.12Ojjaara $32.63Comirnaty $32.27Kyprolis $31.94Myrisk $31.77Besremi $31.59Amtagvi $30.22Zepzelca $28.20Keytruda Qlex $27.72Bavencio $26.97Tibsovo $25.16Tafinlar $23.36Lutathera $23.21Empaveli $22.88Romvimza $21.99Tevimbra $21.95Poteligeo $21.82Nerlynx $21.77Ultomiris $20.80Tgct $19.95Precisetumor $19.69Columvi $19.57Optune Lua (Novottf-200t) $19.45Beleodaq $18.30Clonoseq $18.11Paxlovid $17.87Rezlidhia $17.68Tavalisse $17.68
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Benjamin Jones listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.